For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.* 

JAPNA Article: Cannabidiol or CBD Oil: Help, Hope and Hype for Psychiatric and Neurologic Conditions - Sept-Oct 2020 (26:5) 

CBD is readily available for purchase and is used by the public for various complaints such as pain and sleep without mentioning it in appointments to health care providers. Psychiatric nurse practitioners (PNPs) may not be aware that their patients often use cannabidiol (CBD). Education about CBD has been lacking in nursing programs and educational offerings. Furthermore, most persons who sell and promote over-the-counter CBD retail products lack objective scientific knowledge especially about the adverse effects of CBD.  This article presents PNPs with objective scientific facts to inform and enhance nurses’ knowledge about the evidence-based therapeutic and adverse effects, and potential drug interactions of CBD.

Authors: Marian Newton, PhD, PMHNP-BC, PMHCNS, ANEF; David W. Newton, BS Pharm, PhD, FAPhA  

Disclosures:  The authors and planners have no conflict of interest or commercial support to disclose. Off-label medication use will not be discussed.

Target Audience: APRN 

Learning Outcomes:
Upon completion of this article, the participant will be able to:

1. Identify the difference between the therapeutic effects of cannabidiol (CBD) that have been proven from controlled clinical research studies and those that derive from anecdotes, uncontrolled studies and proprietary promotional claims.
2. Identify specific pharmacologic agonists and receptors in the endocannabinoid system. 
3. Identify the differences in pharmacologic effects between cannabidiol (CBD) and tetrahydrocannibinol (THC). 
4. Identify psychiatric and neurologic conditions for which cannabidiol (CBD) is under investigation in controlled clinical studies for potential new approved therapeutic uses.

Keywords: Cannabidiol, Cannabis, CBD, Endocannabinoids, Hemp

Nursing Continuing Professional Development:
1.25 Pharmacology contact hours.  * In order to receive contact hours, you must: read the entire article, complete an evaluation, and earn a passing score on the post-test. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. You will be able to print or email a certificate once all steps are completed. 

The ability to earn contact hours for this article expires October 31, 2022. 

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.